Jazz Pharmaceuticals holds the cleaner structural position, with the lead spread across profitability and stability. Elanco Animal Health still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels.
The lead is spread across profitability and stability, rather than sitting in one isolated gap. Jazz Pharmaceuticals plc leads by 14 points on the overall comparison score.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
The clearest structural overlap shows up in investment intensity and margin consistency.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Jazz Pharmaceuticals plc still looks stronger, and the price setup does not materially undermine that lead.
Valuation position uses Forward P/E where available.
The profitability lead is mainly driven by a 24.8-point operating margin advantage.
Growth still leans toward Elanco Animal Health Incorporated, so the lead is real without reading as one-way.
The lead is built on both profitability and stability — though growth still provides a counterweight.
Break down the ELAN vs JAZZ comparison across all dimensions with the full interactive tool.
Explore how ELAN and JAZZ each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.